Sign Up Today and Learn More About Complement Therapeutics Stock
Invest in or calculate the value of your shares in Complement Therapeutics or other pre-IPO companies through EquityZen's platform.
Complement Therapeutics Stock (COPT)
Complement Therapeutics operates as a preclinical stage company.
About Complement Therapeutics Stock
Founded
2020
Industries
Software, Artificial Intelligence, Data and Analytics
Complement Therapeutics Press Mentions
Stay in the know about the latest news on Complement Therapeutics
Disposable Contact Lenses Market worth $14.93 Bn by 2031 ...
prnewswire • Dec 24, 2023
GSK, Novartis, among winners at LSX Awards - BioProcess ...
bioprocessintl • Dec 24, 2023
Complement Therapeutics Appoints Dr Parisa Zamiri MD, as Chief Medical Officer
prnewswire • Aug 03, 2023
Complement Therapeutics closes $79M A round for gene therapy in geographic atrophy
bioworld • Apr 19, 2023
Complement Therapeutics Management
Leadership team at Complement Therapeutics
Chief Executive Officer
Rafiq Hasan
Board Member
Anne Horgan
Join now and verify your accreditation status to gain access to:
- Complement Therapeutics current valuation
- Complement Therapeutics stock price
- Available deals in Complement Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Complement Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Complement Therapeutics through EquityZen funds. These investments are made available by existing Complement Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Complement Therapeutics stock?
Shareholders can sell their Complement Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."